Pharvaris NV (PHVS)
22.90
-1.08
(-4.50%)
USD |
NASDAQ |
Nov 05, 16:00
22.90
0.00 (0.00%)
After-Hours: 20:00
Pharvaris Enterprise Value: 926.83M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 926.83M |
| November 01, 2024 | 936.01M |
| October 31, 2024 | 974.89M |
| October 30, 2024 | 971.11M |
| October 29, 2024 | 914.41M |
| October 28, 2024 | 892.80M |
| October 25, 2024 | 804.23M |
| October 24, 2024 | 783.71M |
| October 23, 2024 | 831.23M |
| October 22, 2024 | 839.33M |
| October 21, 2024 | 854.46M |
| October 18, 2024 | 776.69M |
| October 17, 2024 | 779.39M |
| October 16, 2024 | 792.89M |
| October 15, 2024 | 756.16M |
| October 14, 2024 | 742.12M |
| October 11, 2024 | 697.29M |
| October 10, 2024 | 594.68M |
| October 09, 2024 | 599.00M |
| October 08, 2024 | 598.46M |
| October 07, 2024 | 613.04M |
| October 04, 2024 | 614.66M |
| October 03, 2024 | 597.92M |
| October 02, 2024 | 621.14M |
| October 01, 2024 | 627.08M |
| Date | Value |
|---|---|
| September 30, 2024 | 631.95M |
| September 27, 2024 | 633.03M |
| September 26, 2024 | 651.93M |
| September 25, 2024 | 645.45M |
| September 24, 2024 | 657.33M |
| September 23, 2024 | 662.19M |
| September 20, 2024 | 685.41M |
| September 19, 2024 | 770.74M |
| September 18, 2024 | 725.92M |
| September 17, 2024 | 725.38M |
| September 16, 2024 | 744.28M |
| September 13, 2024 | 761.56M |
| September 12, 2024 | 739.96M |
| September 11, 2024 | 764.80M |
| September 10, 2024 | 787.49M |
| September 09, 2024 | 703.78M |
| September 06, 2024 | 664.35M |
| September 05, 2024 | 663.27M |
| September 04, 2024 | 566.60M |
| September 03, 2024 | 579.56M |
| August 30, 2024 | 603.86M |
| August 29, 2024 | 566.06M |
| August 28, 2024 | 601.70M |
| August 27, 2024 | 630.87M |
| August 26, 2024 | 662.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-127.45M
Minimum
Dec 02 2022
1.294B
Maximum
Dec 29 2023
453.93M
Average
399.75M
Median
May 28 2021
Enterprise Value Benchmarks
| uniQure NV | -150.68M |
| ProQR Therapeutics NV | 198.19M |
| Merus NV | 2.874B |
| argenx SE | 32.06B |
| Pharming Group | 488.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.01M |
| Total Expenses (Quarterly) | 37.02M |
| EPS Diluted (Quarterly) | -0.5927 |
| Earnings Yield | -11.39% |